Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC 2 : role of basic residues in the second transmembrane helix

We investigated the role of two conserved basic residues in the second transmembrane helix arginine 172 (R172) and lysine 179 (K179) of the VPAC 2 receptor. Vasoactive intestinal polypeptide (VIP) activated VPAC 2 receptors with an EC 50 value of 7 n M , as compared to 150, 190 and 4000 n M at R172L...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2009-01, Vol.133 (8), p.1249-1254
Hauptverfasser: Vertongen, P, Solano, R M, Perret, J, Langer, I, Robberecht, P, Waelbroeck, M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1254
container_issue 8
container_start_page 1249
container_title British journal of pharmacology
container_volume 133
creator Vertongen, P
Solano, R M
Perret, J
Langer, I
Robberecht, P
Waelbroeck, M
description We investigated the role of two conserved basic residues in the second transmembrane helix arginine 172 (R172) and lysine 179 (K179) of the VPAC 2 receptor. Vasoactive intestinal polypeptide (VIP) activated VPAC 2 receptors with an EC 50 value of 7 n M , as compared to 150, 190 and 4000 n M at R172L, R172Q and K179Q‐VPAC 2 receptors, respectively. It was inactive at K179I mutated VPAC 2 receptors. These results suggested that both basic residues were probably implicated in receptor recognition and activation. The VPAC 2 ‐selective VIP analogue, [hexanoyl‐His 1 ]‐VIP (C 6 ‐VIP), had a higher affinity and efficacy as compared to VIP at the mutated receptors. VIP, Asn 3 ‐VIP and Gln 3 ‐VIP activated adenylate cyclase through R172Q receptors with EC 50 values of 190, 2 and 2 n M , respectively, and through R172L receptors with EC 50 values of 150, 12 and 8 n M , respectively. Asn 3 ‐VIP and Gln 3 ‐VIP behaved as partial agonists at the wild type receptor, with E max values (in per cent of VIP) of 75 and 52%, respectively. In contrast, they were more efficient than VIP (E max values of 150 and 150% at the R172Q VPAC 2 receptors, and of 400 and 360% at the R172L receptors, respectively). These results suggested that the receptor's R172 and the ligand's aspartate 3 are brought in close proximity in the active ligand‐receptor complex. The K179I and K179Q mutated receptors had a lower affinity than the wild‐type receptors for all the agonists tested in this work: we were unable to identify the VIP amino acid(s) that interact with K179. British Journal of Pharmacology (2001) 133 , 1249–1254; doi: 10.1038/sj.bjp.0704195
doi_str_mv 10.1038/sj.bjp.0704195
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1038_sj_bjp_0704195</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_sj_bjp_0704195</sourcerecordid><originalsourceid>FETCH-LOGICAL-c845-a264674ae9bc92b5154f305a441c01ce92c3749f4681fccc1a2f0254520daf703</originalsourceid><addsrcrecordid>eNotkMtqwzAQRUVpoWnabdf6AbuSLfnRXQh9QUq7CN0aWR4RGb_QyKH-jP5xlTabuQNzOQOHkHvOYs7S4gHbuG6nmOVM8FJekBUXeRbJtOCXZMUYyyPOi-Ka3CC2jIVjLlfk5332yttxUB1VYSxokY6G-gPQw9yrgR4Vjkp7ewRqBw_o7ak7weRtA9SBDtvoKM61XyagX5-bLU3oI3VjBydSrdDq0EPbzICB8cdG0OPQUO_UgD30dcjwEDr7fUuujOoQ7s65Jvvnp_32Ndp9vLxtN7tIF0JGKslElgsFZa3LpJZcCpMyqYTgmnENZaLTXJRGZAU3WmuuEsMSKWTCGmVylq5J_I_VbkR0YKrJ2V65peKsOvmssK2Cz-rsM_0Fir5sbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC 2 : role of basic residues in the second transmembrane helix</title><source>Wiley Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Vertongen, P ; Solano, R M ; Perret, J ; Langer, I ; Robberecht, P ; Waelbroeck, M</creator><creatorcontrib>Vertongen, P ; Solano, R M ; Perret, J ; Langer, I ; Robberecht, P ; Waelbroeck, M</creatorcontrib><description>We investigated the role of two conserved basic residues in the second transmembrane helix arginine 172 (R172) and lysine 179 (K179) of the VPAC 2 receptor. Vasoactive intestinal polypeptide (VIP) activated VPAC 2 receptors with an EC 50 value of 7 n M , as compared to 150, 190 and 4000 n M at R172L, R172Q and K179Q‐VPAC 2 receptors, respectively. It was inactive at K179I mutated VPAC 2 receptors. These results suggested that both basic residues were probably implicated in receptor recognition and activation. The VPAC 2 ‐selective VIP analogue, [hexanoyl‐His 1 ]‐VIP (C 6 ‐VIP), had a higher affinity and efficacy as compared to VIP at the mutated receptors. VIP, Asn 3 ‐VIP and Gln 3 ‐VIP activated adenylate cyclase through R172Q receptors with EC 50 values of 190, 2 and 2 n M , respectively, and through R172L receptors with EC 50 values of 150, 12 and 8 n M , respectively. Asn 3 ‐VIP and Gln 3 ‐VIP behaved as partial agonists at the wild type receptor, with E max values (in per cent of VIP) of 75 and 52%, respectively. In contrast, they were more efficient than VIP (E max values of 150 and 150% at the R172Q VPAC 2 receptors, and of 400 and 360% at the R172L receptors, respectively). These results suggested that the receptor's R172 and the ligand's aspartate 3 are brought in close proximity in the active ligand‐receptor complex. The K179I and K179Q mutated receptors had a lower affinity than the wild‐type receptors for all the agonists tested in this work: we were unable to identify the VIP amino acid(s) that interact with K179. British Journal of Pharmacology (2001) 133 , 1249–1254; doi: 10.1038/sj.bjp.0704195</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0704195</identifier><language>eng</language><ispartof>British journal of pharmacology, 2009-01, Vol.133 (8), p.1249-1254</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c845-a264674ae9bc92b5154f305a441c01ce92c3749f4681fccc1a2f0254520daf703</citedby><cites>FETCH-LOGICAL-c845-a264674ae9bc92b5154f305a441c01ce92c3749f4681fccc1a2f0254520daf703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Vertongen, P</creatorcontrib><creatorcontrib>Solano, R M</creatorcontrib><creatorcontrib>Perret, J</creatorcontrib><creatorcontrib>Langer, I</creatorcontrib><creatorcontrib>Robberecht, P</creatorcontrib><creatorcontrib>Waelbroeck, M</creatorcontrib><title>Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC 2 : role of basic residues in the second transmembrane helix</title><title>British journal of pharmacology</title><description>We investigated the role of two conserved basic residues in the second transmembrane helix arginine 172 (R172) and lysine 179 (K179) of the VPAC 2 receptor. Vasoactive intestinal polypeptide (VIP) activated VPAC 2 receptors with an EC 50 value of 7 n M , as compared to 150, 190 and 4000 n M at R172L, R172Q and K179Q‐VPAC 2 receptors, respectively. It was inactive at K179I mutated VPAC 2 receptors. These results suggested that both basic residues were probably implicated in receptor recognition and activation. The VPAC 2 ‐selective VIP analogue, [hexanoyl‐His 1 ]‐VIP (C 6 ‐VIP), had a higher affinity and efficacy as compared to VIP at the mutated receptors. VIP, Asn 3 ‐VIP and Gln 3 ‐VIP activated adenylate cyclase through R172Q receptors with EC 50 values of 190, 2 and 2 n M , respectively, and through R172L receptors with EC 50 values of 150, 12 and 8 n M , respectively. Asn 3 ‐VIP and Gln 3 ‐VIP behaved as partial agonists at the wild type receptor, with E max values (in per cent of VIP) of 75 and 52%, respectively. In contrast, they were more efficient than VIP (E max values of 150 and 150% at the R172Q VPAC 2 receptors, and of 400 and 360% at the R172L receptors, respectively). These results suggested that the receptor's R172 and the ligand's aspartate 3 are brought in close proximity in the active ligand‐receptor complex. The K179I and K179Q mutated receptors had a lower affinity than the wild‐type receptors for all the agonists tested in this work: we were unable to identify the VIP amino acid(s) that interact with K179. British Journal of Pharmacology (2001) 133 , 1249–1254; doi: 10.1038/sj.bjp.0704195</description><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNotkMtqwzAQRUVpoWnabdf6AbuSLfnRXQh9QUq7CN0aWR4RGb_QyKH-jP5xlTabuQNzOQOHkHvOYs7S4gHbuG6nmOVM8FJekBUXeRbJtOCXZMUYyyPOi-Ka3CC2jIVjLlfk5332yttxUB1VYSxokY6G-gPQw9yrgR4Vjkp7ewRqBw_o7ak7weRtA9SBDtvoKM61XyagX5-bLU3oI3VjBydSrdDq0EPbzICB8cdG0OPQUO_UgD30dcjwEDr7fUuujOoQ7s65Jvvnp_32Ndp9vLxtN7tIF0JGKslElgsFZa3LpJZcCpMyqYTgmnENZaLTXJRGZAU3WmuuEsMSKWTCGmVylq5J_I_VbkR0YKrJ2V65peKsOvmssK2Cz-rsM_0Fir5sbg</recordid><startdate>20090129</startdate><enddate>20090129</enddate><creator>Vertongen, P</creator><creator>Solano, R M</creator><creator>Perret, J</creator><creator>Langer, I</creator><creator>Robberecht, P</creator><creator>Waelbroeck, M</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20090129</creationdate><title>Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC 2 : role of basic residues in the second transmembrane helix</title><author>Vertongen, P ; Solano, R M ; Perret, J ; Langer, I ; Robberecht, P ; Waelbroeck, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c845-a264674ae9bc92b5154f305a441c01ce92c3749f4681fccc1a2f0254520daf703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vertongen, P</creatorcontrib><creatorcontrib>Solano, R M</creatorcontrib><creatorcontrib>Perret, J</creatorcontrib><creatorcontrib>Langer, I</creatorcontrib><creatorcontrib>Robberecht, P</creatorcontrib><creatorcontrib>Waelbroeck, M</creatorcontrib><collection>CrossRef</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vertongen, P</au><au>Solano, R M</au><au>Perret, J</au><au>Langer, I</au><au>Robberecht, P</au><au>Waelbroeck, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC 2 : role of basic residues in the second transmembrane helix</atitle><jtitle>British journal of pharmacology</jtitle><date>2009-01-29</date><risdate>2009</risdate><volume>133</volume><issue>8</issue><spage>1249</spage><epage>1254</epage><pages>1249-1254</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>We investigated the role of two conserved basic residues in the second transmembrane helix arginine 172 (R172) and lysine 179 (K179) of the VPAC 2 receptor. Vasoactive intestinal polypeptide (VIP) activated VPAC 2 receptors with an EC 50 value of 7 n M , as compared to 150, 190 and 4000 n M at R172L, R172Q and K179Q‐VPAC 2 receptors, respectively. It was inactive at K179I mutated VPAC 2 receptors. These results suggested that both basic residues were probably implicated in receptor recognition and activation. The VPAC 2 ‐selective VIP analogue, [hexanoyl‐His 1 ]‐VIP (C 6 ‐VIP), had a higher affinity and efficacy as compared to VIP at the mutated receptors. VIP, Asn 3 ‐VIP and Gln 3 ‐VIP activated adenylate cyclase through R172Q receptors with EC 50 values of 190, 2 and 2 n M , respectively, and through R172L receptors with EC 50 values of 150, 12 and 8 n M , respectively. Asn 3 ‐VIP and Gln 3 ‐VIP behaved as partial agonists at the wild type receptor, with E max values (in per cent of VIP) of 75 and 52%, respectively. In contrast, they were more efficient than VIP (E max values of 150 and 150% at the R172Q VPAC 2 receptors, and of 400 and 360% at the R172L receptors, respectively). These results suggested that the receptor's R172 and the ligand's aspartate 3 are brought in close proximity in the active ligand‐receptor complex. The K179I and K179Q mutated receptors had a lower affinity than the wild‐type receptors for all the agonists tested in this work: we were unable to identify the VIP amino acid(s) that interact with K179. British Journal of Pharmacology (2001) 133 , 1249–1254; doi: 10.1038/sj.bjp.0704195</abstract><doi>10.1038/sj.bjp.0704195</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2009-01, Vol.133 (8), p.1249-1254
issn 0007-1188
1476-5381
language eng
recordid cdi_crossref_primary_10_1038_sj_bjp_0704195
source Wiley Journals; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection
title Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC 2 : role of basic residues in the second transmembrane helix
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A57%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutational%20analysis%20of%20the%20human%20vasoactive%20intestinal%20peptide%20receptor%20subtype%20VPAC%202%20:%20role%20of%20basic%20residues%20in%20the%20second%20transmembrane%20helix&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Vertongen,%20P&rft.date=2009-01-29&rft.volume=133&rft.issue=8&rft.spage=1249&rft.epage=1254&rft.pages=1249-1254&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.bjp.0704195&rft_dat=%3Ccrossref%3E10_1038_sj_bjp_0704195%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true